| Jamie Tooles, RN | |
|
840 Fred St Apt 21, Lansing, MI 48911-3982 | |
| (517) 928-3045 | |
| Not Available |
| Full Name | Jamie Tooles |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 840 Fred St Apt 21, Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316336928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703113415 (Michigan) | Secondary |
| 163W00000X | Registered Nurse | 4704337211 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Tooles, RN 840 Fred St Apt 21, Lansing, MI 48911-3982 Ph: (517) 928-3045 | Jamie Tooles, RN 840 Fred St Apt 21, Lansing, MI 48911-3982 Ph: (517) 928-3045 |
News Archive
Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.
ULURU Inc. today announced its financial results for the first quarter ended March 31, 2010.
More than 80 percent of all waste from Pennsylvania's oil and gas drilling operations stays inside the state, according to a new study that tracks the disposal locations of liquid and solid waste from these operations across 26 years.
Young women at low risk for coronary heart disease and cardiovascular diseases have a lower long-term death rate from these diseases and all other causes compared with others with higher risk factor levels, according to an article in the October 6 issue of JAMA.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
› Verified 1 days ago
Melissa Margo Black, MSN, PMHNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3475 Belle Chase Way, Lansing, MI 48911 Phone: 517-882-3732 | |
Christine Grabarek, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 812 E Jolly Rd, Ste 112, Lansing, MI 48910 Phone: 517-346-8403 Fax: 517-346-8291 | |
Mary J Huffman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 812 E Jolly Rd, Suite G-14, Lansing, MI 48910 Phone: 517-346-8275 Fax: 517-346-8290 | |
Craig Michael Obrien, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 | |
Sarah Sproull, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2900 Collins Rd, Lansing, MI 48910 Phone: 517-975-7300 | |
Annette L Schulz, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1209 Wolf Run Dr, Lansing, MI 48917 Phone: 517-899-4827 | |
Lisa Marie Schmitt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 812 E Jolly Rd, Suite 215, Lansing, MI 48910 Phone: 517-346-8467 Fax: 517-346-8291 |